ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

521
Analysis
Health Care • China
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
bearish•WuXi XDC Cayman
•08 May 2024 07:00

Wuxi XDC Lock-Up - US$300m Lockup Expiry Could See Some Selling Owing to the Regulatory Overhang

WuXi XDC Cayman (2268 HK) was listed in Hong Kong on 17th Nov 2023 after raising US$470m. Its six-month lockup will expire on 16th May 2024.

Logo
636 Views
Share
•06 May 2024 07:30

HK Strategy: Where Are the Short-Term Opportunities?

Li Auto, Link REIT, China Mengniu, Hang Lung Properties, and Galaxy Entertainment are massive laggards YTD but the recent rebound from the trough...

Logo
525 Views
Share
bullish•WuXi AppTec
•02 May 2024 19:37•Broker

WuXi AppTec (603259 CH) - Steady 1Q Performance Amid Challenging Environment

WuXi AppTec reported 1Q24 revenue of RMB7,982mn, down 11.0% YoY, attributable recurring net profit of RMB2,034mn, up 7.3% YoY

Logo
249 Views
Share
bullish•Quantitative Analysis
•10 Apr 2024 07:08

Hong Kong: Q1 Short Interest Recap

Short notional in Hong Kong is HK$338bn and has been falling over the last 3 years due to a drop in the market. We look at stocks that have seen...

Logo
650 Views
Share
bearish•Quantitative Analysis
•07 Apr 2024 10:05

Northbound Flows (Apr 3rd): CATL, Moutai

We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for CATL, Moutai. Not e that connect scheme was closed...

Logo
469 Views
Share
x